Delivery Order SPE2DB22D3009-SPE2DB25FBC49
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of OxyContin Tablets 30mg to the Defense Logistics Agency's Medical Supply Chain. The contract, valued at $1,541.40 with a firm fixed-price structure, carries an ultimate completion date of August 6, 2025, and will be fulfilled at the vendor's Conshohocken, PA facility. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,215.82, represents a non-competitive set-aside contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,161.00 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count) valued at $1,640.40, with a firm fixed-price contract type and an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBC49Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen serves as a primary pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of pharmaceuticals and medical commodities to support military and veteran healthcare systems. As a major healthcare solutions provider, the company has demonstrated consistent capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains. This delivery order represents a routine pharmaceutical supply transaction within the broader strategic relationship between AmerisourceBergen and the DLA, which enables flexible support for Defense Health Agency operations and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/5/25 |